- Home
- QTRX
as 06-30-2025 1:33pm EST
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | BILLERICA |
| Market Cap: | 233.5M | IPO Year: | 2017 |
| Target Price: | $15.60 | AVG Volume (30 days): | 903.5K |
| Analyst Decision: | Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.24 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.05 - $16.74 | Next Earning Date: | 08-07-2025 |
| Revenue: | $135,688,000 | Revenue Growth: | 7.71% |
| Revenue Growth (this year): | -7.51% | Revenue Growth (next year): | 14.49% |
Stock Insider Trading Activity of Quanterix Corporation (QTRX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| WALT DAVID R | QTRX | Director | Jun 12 '25 | Buy | $6.18 | 160,000 | $984,968.49 | 1,742,943 | |
| Toloue Masoud | QTRX | President & CEO | Jun 9 '25 | Buy | $5.42 | 45,900 | $248,722.92 | 518,922 | |
| DONNELLY WILLIAM P | QTRX | Director | Jun 6 '25 | Buy | $5.44 | 93,113 | $506,348.49 | 139,094 | |
| WALT DAVID R | QTRX | Director | Jun 6 '25 | Buy | $5.39 | 210,000 | $1,133,795.69 | 1,742,943 |
Latest Quanterix Corporation News
QTRX Breaking Stock News: Dive into QTRX Ticker-Specific Updates for Smart Investing
MT Newswires
7 days ago
Quanterix Expands Global Access for Biomarker Detection Platform with South Korea Approval
Business Wire
8 days ago
Quanterix Expands Reach with IVD and Large Reference Labs
Argus Research
15 days ago
Daily – Vickers Top Buyers & Sellers for 06/16/2025
MT Newswires
17 days ago
Quanterix Insider Bought Shares Worth $984,968, According to a Recent SEC Filing
Simply Wall St.
19 days ago
Insider Spends US$1.1m Buying More Shares In Quanterix
PR Newswire
20 days ago
Kent Lake Condemns Quanterix's Failure to Schedule Its 2025 Annual Meeting as a Tactic to Silence Shareholders
Argus Research
20 days ago
Daily – Vickers Top Buyers & Sellers for 06/11/2025
Argus Research
21 days ago
Daily – Vickers Top Buyers & Sellers for 06/10/2025
Compare QTRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "QTRX Quanterix Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.